Pfizer (PFE) and Arvinas (ARVN) aim to seek FDA approval for thier breast cancer therapy vepdegestrant in H2 2025. Read more ...

Sempra reiterated its end-2025 final investment decision (FID) target, but said that while commercial interest is strong, macroeconomic issues could ...

Copyright: © 2015 Elsevier Ltd. Published by Elsevier Ltd.

The foreign secretary condemns Israel's latest actions in Gaza as "monstrous" and "dangerous" - but stops short of saying it ...

The Israeli government said Tuesday that it will not stop its new military campaign in the Gaza Strip despite pressure from ...

Kerem Shalom is a solely commercial goods junction with Israel in southern Gaza. There are two other border crossings from ...

Hundreds of Palestinians have been killed in recent days as Israel has intensified air strikes, the Hamas-run health ministry ...

While Tel Aviv weakens, Jerusalem’s luxury market soars due to foreign buyers, boutique projects, and rich Jewish history - ...

Despite the positive results, the company faces the uncertainty of upcoming clinical trials, particularly the Phase 2 trial, which may not yield the same favorable results as the Phase 1b trial.

But with promising early results from a phase 3 study in certain patients, the checkpoint inhibitor may have found its place. At a pre-specified interim analysis of Merck’s phase 3 Keynote-B96 ...

ATRN-119, our ATR inhibitor, exhibits early evidence of single agent, anti-tumor activity and is progressing toward the recommended Phase 2 dose (RP2D) in the ongoing ABOYA-119 clinical trial Three ...

Palestinians in Gaza may face starvation within weeks if aid is not allowed in soon, Israeli defence officials have admitted. Three military officers monitoring the situation in Gaza said many areas ...